Why "covert vaccinees" are keeping their vaccine status a secret, whether blue light glasses really work, and more.
Why Fauci is warning of another potential coronavirus surge (Monday, March 15)
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, last week said Europe's recent surge in cases of the novel coronavirus should serve as a warning for the United States.
Why 'covert vaccinees' are keeping their vaccine status a secret (Tuesday, March 16)
Writing for The Atlantic, Katherine Wu profiles 12 people who have received the Covid-19 vaccine but opted to keep their newly vaccinated status a secret—revealing "a harrowing form of eligibility warfare" that could contribute to people's reluctance to get vaccinated at all.
'Like I wasn't there': What it's like to survive 'locked-in syndrome' (Wednesday, March 17)
Jake Haendel suffered for months from "locked-in syndrome," a rare phenomenon in which a patient is unable to move or communicate but remains fully conscious. But unlike most locked-in patients, Haendel recovered—and now he's sharing his experience, Josh Wilbur writes for The Guardian.
Blue light glasses are booming—but do they really work? (Thursday, March 18)
As more people spend their entire work day in front of a computer, sales of blue light glasses—which incorporate special lenses that filter out certain light waves emitted by digital devices—have boomed. But do these glasses actually reduce eye strain or improve sleep?
Map: The states with the highest (and lowest) vaccine completion rates (Friday, March 19)
New CDC research indicates that the vast majority of Americans who have received their first Covid-19 vaccine shot returned to receive their second shot—but there were some significant caveats. Find out how your state is faring on our interactive map.
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
Never miss out on the latest innovative health care content tailored to you.